Update, November 3, 2026
Since the October 21 report, FXI has edged up 2.1% over the past five sessions, closing at $33.17 on November 3, even as the S&P 500 fell 1.6% over the same stretch. The relative strength is modest and does not alter the broader downtrend; the ETF remains below its 40-week average and its 50-day moving average at $34.09. A Bloomberg Business report from October 30 notes Chinese investors are shifting into long-bond ETFs as domestic stocks sink, a sentiment that aligns with the persistent weakness in Chinese equities.
The picture holds. The price is still below the key $34.09 (sma_50) level, and the weekly downtrend remains intact. The 52-week low at $31.59 is now just 5% below the current price, making a downside breakout a near-term possibility. Resistance levels have not moved: $34.09, $34.64 (swing zone), $35.00, $35.32, and $35.60 (sma_200) all remain overhead. Support is unchanged at $31.59, $30.00, and $25.00. The RSI at 39.82 suggests momentum is weak but not oversold. A weekly close above $34.64 would change the picture, but that is still 4.4% away.
The 5-day gain of 2.1% contrasts with the S&P 500's 1.6% decline, but the ETF remains down 1.4% relative to the S&P 500 over 50 days and 10.6% over 200 days. The recent peak of $34.26 on October 15 has been followed by a 3.2% drop, reinforcing the bearish stance. No new catalysts have emerged to alter the assessment; the October 30 bond-flow story underscores investor caution. The next earnings date is January 19, 2017, but no analyst data is available. The picture holds.
iShares China Large-Cap ETF (FXI) trades at $33.07 on October 21, 2026, down 1.3% on the day while the S&P 500 edged higher. The balance of evidence for the next two to six weeks leans negative, with medium conviction. The fund sits below its 50-day, 200-day and 40-week averages and has lagged SPY by 3.3% over 50 days. Cheap valuation is the main argument against that reading, but price has not yet agreed with it.
Why it matters
No single event explains today's drop. The newest items in the news flow are from late September, and nothing dated October accounts for a 1.3% fall on a day when SPY rose 0.3%. What the September headlines do show is a steady stream of weak Chinese demand. The Financial Times reported Toyota's China sales down 23% in August, the seventh straight monthly fall, with year-to-date sales off nearly 19% as high fuel prices and the shift to electric vehicles bit. The Wall Street Journal described Nike's China revenue as nearly 30% below its peak. iHuman's second-quarter revenue fell 17.8% on a shrinking newborn population and cautious consumers. These are not reports on FXI's own holdings. They are evidence about the consumer demand the basket's theme leans on.
The market's reaction fits that backdrop. FXI peaked at a $35.00 close on September 22 and is now 5.5% below it. It is down 5.3% over a month, 10.9% over six months and 13.6% year to date, while SPY is up 12.8% for the year. Policy hopes have faded too: Reuters said hopes for a new Boeing order around the upcoming US-China summit were dimming. A stronger dollar and higher Treasury yields, which Morningstar cited in September, are not a friendly backdrop for China-linked assets.
Over five days FXI fell 2.3% and SPY fell 1.2%. The broad market explains roughly half of the slide, and the rest is specific to China exposure. No sector fund is available for comparison, so that residual cannot be split further. Midsession volume is far below its 20-day average, so today's drop is a modest signal until the session closes.
The argument for the basket is valuation and earnings. Morningstar profiled Rob Vinall of RV Capital, who has lifted Chinese stocks to about a third of his portfolio. His case rests on MSCI China trading near 11.4 times earnings against 21.1 in the article's comparison. CNBC reported Goldman Sachs pointing to China healthcare after nearly half of MSCI China constituents beat second-quarter estimates. The case against is that cheapness has persisted for months without stopping the decline, and the demand data above are still deteriorating. There is no analyst target spread for the fund, so valuation here is a statement about the index, not about a price target.
What the evidence says
The long-term trend is down. Price is below its 40-week average and the 200-day average at $35.92, and the fund is 19.5% under its 52-week high of $41.08. That is a weakened thesis in a persistent downtrend, not a broken one. The fund is only 4.7% above its 52-week low of $31.59, so the question is whether that floor holds. Against SPY the gap is 3.3% over 50 days and 12.4% over 200 days, so the lag is long-standing.
For the next two to six weeks the balance of evidence leans negative, with medium conviction, 2 of 4 points. Two things support it: the daily trend runs with the weekly downtrend, and the fund is lagging the S&P 500. The 50-day average at $34.56 has capped rallies, and the RSI of 40.9 shows weak momentum without an oversold washout.
The strongest case against is valuation and earnings: an index at roughly half the multiple of the comparison market, and widespread second-quarter beats. Price is also close to its low, and the first downside target gives only 0.5 to 1. That is why conviction is medium and not higher. It does not tip the balance because the trend, relative weakness and demand data all point the same way, and cheap markets can stay cheap while earnings beats go unrewarded.
Levels that matter
In a downtrend the structure holds below $34.56, the 50-day average, where sellers have shown up on rallies. The trend would end above $35.32, a swing zone, on a weekly close. Between them sit the round $35.00 and, higher, the 200-day average at $35.92. That makes the zone from $34.56 to $35.92 the crowded ceiling.
The breakout level on the downside is a daily close below $31.59, the 52-week low. From there the first target is $30.00 and the second is $25.00. A stop at $34.67, the 50-day average plus a quarter of the 14-day ATR of $0.45, marks where the move would be wrong. Reward-to-risk is 0.5 to 1 for $30 and 2.1 to 1 for $25. The math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a much tighter stop or a target well below $25 to get there.
What would change the picture
A weekly close above $35.32 would be the first sign that buyers are back and that the weekly downtrend is ending. The non-price fact most likely to produce it is evidence that Chinese consumer demand has stabilized, such as car sales ending their string of monthly declines. That would give the valuation argument the earnings support it currently lacks.
What to watch
- Chinese auto and consumer data. Toyota's seven straight monthly declines are the clearest recent marker of weak demand.
- The US-China summit. The data give no date, but the fading Boeing hopes show expectations are low.
- The dollar and Treasury yields, which strengthened in September and weigh on China-linked assets.
- Relative strength against SPY. A narrowing of the 3.3% gap over 50 days would be the earliest sign of improvement. No fund flow or holdings changes appear in the available news.
- The $34.56 50-day average on rallies and $31.59 on declines.